Home
About
Overview
Sharing Data
ORCID
Help
History (32)
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
Comparing post-operative human breast specimen radiograph and MRI in lesion margin and volume assessment.
Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial.
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.
Characterizing the distribution of alterations in mesothelioma and their correlation to morphology.
See All 32 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Characterizing the distribution of alterations in mesothelioma and their correlation to morphology.
Characterizing the distribution of alterations in mesothelioma and their correlation to morphology. Am J Clin Pathol. 2023 09 01; 160(3):238-246.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
Female
Humans
Immunohistochemistry
Lung Neoplasms
Male
Mesothelioma
Middle Aged
Pleural Neoplasms
Sarcoma
Tumor Suppressor Proteins
Ubiquitin Thiolesterase
authors with profiles
Melissa Tjota
Hedy Kindler